GSK took center stage last month, forming standout partnerships and alliances across multiple therapeutic areas.

Explore how biotech breakthroughs in 2024 have changed lives, bringing real Christmas miracles to patients and offering hope ...

Discover the history of Japan's biopharma industry and whether it is now set for an upswing after years of stagnation from ...

One of the biggest buyouts last month was Swiss pharma giant Roche’s $1.5 billion dollar acquisition of cell and gene therapy developer Poseida Therapeutics. This will see Roche nab the CAR-T ...

The integration of artificial intelligence (AI) in the biotech industry seems boundless. Its combination with CRISPR could be the one area where AI has the most potential. Nobel prize winner and ...

Asking whether China is the future of the biotech industry might seem counterintuitive, considering the current biotech geopolitical context. If you haven’t followed this series of events, a ...

The biggest private biotech funding round of November 2024 went to Metsera, which raised $215 million in series B funding. The company is focused on advancing the next generation of therapies for ...

Cancer vaccines are a kind of immunotherapy that are meant to recognize cancer cells in the body and destroy them. But what if they could prevent the spread of cancer altogether? Well, that’s ...

When German scientists posted data in 2022 showing that CAR-T cell therapy could be effective in treating systemic lupus erythematosus, interest in the field quickly took off. More recently, spurring ...

As 2024 comes to a close, and while we will soon be thinking about 2025 and the trends that will shape the biotech industry, now is a good time to look back at what happened this year. Earlier this ...